Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Clinical Trials: Overview01:11

Clinical Trials: Overview

3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Pharmacovigilance01:19

Pharmacovigilance

838
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
838
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

264
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
264
Clinical Trials01:16

Clinical Trials

6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.7K
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

736
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
736
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

129
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
129

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Patient preferences for treatment attributes in osteoarthritis: protocol for a systematic review of stated preference studies.

BMJ open·2026
Same author

From model validation to policy resilience: stress testing healthcare systems with AI and cross-sectorial methodology.

Expert review of pharmacoeconomics & outcomes research·2026
Same author

Patients' Preferences for Surgical Procedures in Hidradenitis Suppurativa: A Discrete Choice Experiment.

The patient·2026
Same author

Vascular Access Surgery Timing: A Prospective European Cohort Study in Elderly Patients with ESKD.

Kidney360·2026
Same author

Medication adherence research: expert perspectives on key HEOR trends for 2026.

Expert review of pharmacoeconomics & outcomes research·2026
Same author

Prevention, artificial intelligence, and mathematics in health economics: a framework for dynamic value modeling under long-term uncertainty.

Expert review of pharmacoeconomics & outcomes research·2026

相关实验视频

Updated: Jul 6, 2025

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure
15:18

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure

Published on: July 30, 2009

18.2K

儿科市场准入:一个定性研究

Lieke Maas1, Angelika Joos2, Mickael Hiligsmann3

  • 1Department of Health Services Research, Care and Public Health Research Institute (CAPHRI), Maastricht University, P.O Box 616, 6200 MD, Maastricht, The Netherlands. lieke.maas@maastrichtuniversity.nl.

Therapeutic innovation & regulatory science
|January 3, 2024
PubMed
概括

导航儿科药物市场准入需要解决监管和报销障碍. 协调要求和实施国家特定的定价模式可以改善患者获得基本药物的机会.

关键词:
进入市场的市场准入权.儿科药物 儿科药物 儿科药物儿科法规 儿科法规儿科 儿科 儿科退款方式 退款方式 退款方式

更多相关视频

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
09:18

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy

Published on: January 12, 2019

10.4K
Assessment of the Efficacy of An Osteopathic Treatment in Infants with Biomechanical Impairments to Suckling
07:11

Assessment of the Efficacy of An Osteopathic Treatment in Infants with Biomechanical Impairments to Suckling

Published on: February 5, 2019

9.0K

相关实验视频

Last Updated: Jul 6, 2025

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure
15:18

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure

Published on: July 30, 2009

18.2K
Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
09:18

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy

Published on: January 12, 2019

10.4K
Assessment of the Efficacy of An Osteopathic Treatment in Infants with Biomechanical Impairments to Suckling
07:11

Assessment of the Efficacy of An Osteopathic Treatment in Infants with Biomechanical Impairments to Suckling

Published on: February 5, 2019

9.0K

科学领域:

  • 制药科学 制药科学
  • 卫生政策 卫生政策
  • 监管事务 监管事务

背景情况:

  • 儿童药物开发面临着独特的监管和市场准入挑战.
  • 目前欧洲儿科药品进入市场的途径复杂且分散.

研究的目的:

  • 分析欧洲当前的儿科医学 (PM) 监管和市场准入要求.
  • 为减轻儿科市场准入方面的挑战提出解决方案.

主要方法:

  • 定性研究涉及22个半结构面试与各种利益相关者 (行业,监管机构,HTA机构,临床医生,学术界).
  • 采访涵盖了荷兰,德国,英国和法国的儿科研究,监管/报销流程,挑战和解决方案.
  • 使用Atlas.ti 9进行主题分析,以确定促进儿科市场准入的关键因素.

主要成果:

  • 欧洲药品署 (EMA) 和卫生技术评估 (HTA) 批准要求存在显著的异质性.
  • 德国提供批准后的直接退款,而其他国家要求采取额外的步骤,导致延迟.
  • 促进因素包括多方利益相关者合作,透明度,患者参与,现实世界的证据和定制的临床试验设计.
  • 具体的国家定价模式和儿科激励措施对于创新和及时的患者接入至关重要.

结论:

  • 监管和补偿审批流程的差异在欧洲为儿科药物制造障碍.
  • 价格和退款程序的国际变化需要战略方法来优化儿科市场准入.